(RTTNews) - GE Healthcare said Monday that the U.S. Food and Drug Administration approved Clariscan, a macrocyclic, ionic, gadolinium-based, MRI contrast agent, expanding the GE Healthcare portfolio ...
Clariscan, approved in more than 55 countries globally with over four million patient doses shipped, is now FDA-approved in the U.S. Expands the GE Healthcare portfolio of contrast media products “The ...
Complimentary Educational Session Scheduled for March 11 As imaging volumes continue to grow, virtual supervision ...
Preparing for a Magnetic Resonance Imaging (MRI) scan involves several essential steps to ensure the procedure is both safe and yields the clearest possible images.
When you get a magnetic resonance imaging (MRI) scan, you might get an injection of a contrast fluid called gadolinium, a kind of “dye” that highlights your organs, blood vessels, and tissues to ...
Magnetic resonance imaging (MRI) contrast agents have had a significant impact on the value of MRI by enhancing the visibility of internal bodily structures such as organs and vasculature. MRI ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--GE Healthcare’s innovative shatterproof polymer +PLUSPAK Pharmacy Bulk Package has been approved by the US FDA for use with its macrocyclic gadolinium-based MRI ...
BERLIN--(BUSINESS WIRE)--Bayer, a global leader in radiology, today announced positive topline results of the pivotal Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane, an ...
Contrast agents used to improve views of the heart on MRI carry a very low risk of allergic reactions, vomiting and other acute adverse events, according to a large study from Europe published in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results